J&J Banner (2).png

 

Johnson & Johnson MedTech is a global leader in surgical innovation, delivering trusted Ethicon™ wound closure solutions designed to support healthcare professionals across a wide range of surgical procedures.

 

Trusted by hospitals and surgical teams throughout Australia and New Zealand, the Ethicon™ portfolio includes absorbable and non-absorbable sutures alongside DERMABOND™ skin closure solutions, providing healthcare professionals with a range of options to support effective tissue approximation, wound closure and patient care.

 

 
Johnson & Johnson MedTech

Absorbable Sutures.png

 

The Ethicon Absorbable Suture Range

MONOCRYL™
Synthetic monofilament absorbable suture offering smooth tissue passage and predictable absorption.

VICRYL RAPIDE™
Braided absorbable suture designed for short-term wound support and rapid absorption.

VICRYL PLUS™
Braided absorbable suture with antibacterial technology for soft tissue approximation and ligation.

MONOCRYL PLUS™
Monofilament absorbable suture combining MONOCRYL™ characteristics with antibacterial technology.

STRATAFIX™ Spiral MONOCRYL™ Plus
Undyed, absorbable monofilament barbed suture designed for knotless tissue approximation.

J&J Absorbable Suture Portfolio

Designed to support healing in three ways

A range of absorbable suture technologies designed to support different wound closure requirements.

Predictable Absorption

Different absorption and strength retention profiles provide wound support during healing before the suture is gradually absorbed by the body. 

Versatile Construction

Monofilament, braided and barbed options provide a choice of suture constructions to support different surgical applications and tissue requirements.

Broad Clinical Choice

A range of materials, sizes and absorption profiles allows healthcare professionals to select a suture suited to the tissue, procedure and required wound support.

 

 

Non-Absorbable Sutures.png

The Ethicon Non-Absorbable Suture Range

 

ETHILON™
Synthetic monofilament nylon sutures available in a range of sizes and needle configurations.

PROLENE™
Synthetic monofilament polypropylene sutures designed for prolonged tissue support.

PERMA-HAND™
Braided silk sutures offering handling characteristics suited to soft tissue approximation and ligation.

ETHILON™ Nylon Suture

Designed for lasting tissue support

A range of non-absorbable suture technologies designed to provide sustained support across different surgical applications.

Maintained tensile strength

Designed to retain mechanical strength over time where prolonged tissue support is required.

Knot Security

Suture materials and constructions are designed to provide dependable knot security and handling characteristics to support surgical closure.

Long-Term Support

A range of non-absorbable materials provide continued structural support where tissue approximation or reinforcement is required over an extended period.

 

 

Dermabond Banner.png

 

DERMABOND™ is a range of sterile topical skin closure solutions designed for healthcare professionals to hold together easily approximated skin edges of surgical incisions and simple, thoroughly cleansed traumatic lacerations. Using 2-octyl cyanoacrylate adhesive technology, DERMABOND™ provides secure skin closure while forming a flexible microbial barrier.

The portfolio includes DERMABOND ADVANCED™, DERMABOND Mini and DERMABOND™ PRINEO™, offering different application and closure options. PRINEO™ combines topical skin adhesive with a self-adhering mesh to support skin edge approximation across longer surgical incisions.

 

 

 

 

 

DERMABOND™ PRINEO™ Skin Closure System

Fortify your skin closure in three ways

Evidence-backed performance characteristics of DERMABOND® Topical Skin Adhesive

.

Strengthens

When used alongside sutures, DERMABOND® Topical Skin Adhesive was shown ex vivo to add 75% more strength to wound closure compared with sutures alone.

Inhibits Bacteria

In vitro testing demonstrated inhibition of gram-positive bacteria (MRSA and MRSE) and gram-negative bacteria (E. coli) for 48 ± 2 hours.

Provides a Microbial Barrier

Provides a flexible microbial barrier with >99% protection in vitro for at least 72 hours against organisms commonly associated with surgical site infections.

 

Explore the DERMABOND® Range 

DERMABOND ADVANCED™

Topical skin adhesive featuring a high-viscosity formulation and applicator designed for controlled application.

DERMABOND™ Mini

A smaller-volume topical skin adhesive designed for application in multiple thin layers.

DERMABOND™ PRINEO™

A skin closure system combining 2-octyl cyanoacrylate adhesive with a self-adhering mesh for surgical skin closure.

DERMABOND range

 

dermabond_prineo_no_bg.png

DERMABOND™ PRINEO™ Skin Closure System

  • Combines 2-octyl cyanoacrylate adhesive with a self-adhering mesh for topical skin closure.
  • The mesh helps distribute closure forces across the skin surrounding the incision.
  • The adhesive polymerises over the mesh to create a protective layer over the incision.

Designed for surgical skin closure

  • Designed for use on easily approximated skin edges following surgical incisions.
  • The system provides topical wound closure without requiring conventional skin sutures or staples at the skin surface.
DERMABOND PRINEO Skin Closure System

 

DERMABOND® Technical Overview

  • DERMABOND® skin closure products use 2-octyl cyanoacrylate (2-OCA) technology to provide topical wound closure and a protective microbial barrier.
  • The DERMABOND® range includes topical skin adhesive and adhesive-plus-mesh systems, with formulations and application characteristics designed for different wound-closure requirements.

 

 

 

*Microbial barrier performance based on in-vitro testing. Refer to the relevant product Instructions for Use for complete indications, contraindications, warnings and precautions.

 

1 Adhesive volume range as provided for DERMABOND™ PRINEO™.
2 Microbial barrier protection in vitro (reference as provided).

Technical characteristic DERMABOND ADVANCED™ DERMABOND™ MINI DERMABOND™ PRINEO™
Adhesive technology 2-octyl cyanoacrylate (2-OCA) 2-octyl cyanoacrylate (2-OCA) 2-octyl cyanoacrylate (2-OCA) + self-adhering mesh
Closure mechanism Forms a flexible polymeric film over approximated skin edges Forms a flexible polymeric film over approximated skin edges Adhesive polymerises over the mesh, which distributes closure forces across the skin
Adhesive Volume 0.7 mL 0.36 mL 2.9–3.8 mL1
Application Single layer ≥2 thin layers Single layer over mesh
Approx. Drying Time 1.7 minutes 2.4 minutes 60 seconds
Microbial barrier 99% protection in vitro for 72 hours2 99% protection in vitro for 72 hours2 99% protection in vitro for 72 hours2

 

Additional Resources

J&J Header (1).png

 

Transition from Gut Sutures 

 

Johnson & Johnson MedTech is transitioning from Surgical Gut Sutures (Chromic and Plain Gut), with the final sales date in Australia being 31 August 2026. The accompanying guide outlines recommended alternative products, key transition information and clinical considerations to help support product selection during this change.  

 

 

Latest Full Letter (4).png

 

View Our Latest Letter

 

As the 31st August 2026 final sales date approaches, some surgical gut sutures products are now unavailable or in limited supply. View the latest update for current supply status, affected product codes, and recommended alternative products to help support a smooth transition.  

 
 
 

Plastics  (8).png

 

Why Choose Synthetic Absorbable Sutures?

 

Discover why surgeons are increasingly choosing synthetic absorbable sutures over gut sutures. This guide explores real-world clinical insights, predicable tensile strength retention, ease of handling, and other key considerations to support product selection.